Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
|
Buy Now
Dyslipidemia (Paperback)
Loot Price: R1,182
Discovery Miles 11 820
|
|
Dyslipidemia (Paperback)
Series: Oxford American Cardiology Library
Expected to ship within 12 - 17 working days
|
Dyslipidemia affects almost half of American adults and is the most
prevalent manageable risk factor for atherosclerosis. Lipid
disorders often co-occur with other prevalent conditions such as
diabetes and kidney disease; they are also often a concern with
certain medication regimens (such as anti-retroviral and certain
anti-psychotic agents). Proper treatment of dyslipidemia can reduce
the risk of peripheral arterial disease, revascularization
procedures, nonfatal myocardial infarction, stroke, and cardiac
death. However, only 20% of adults meet the national guidelines for
cholesterol control. As part of the Oxford American Cardiology
Library, this practical handbook is designed to serve as a concise
yet authoritative resource on diagnosing and treating dyslipidemia.
The book is tailored to the needs of busy health care professionals
treating patients in various clinical settings, and focuses on
presenting essential information to clinicians who are at the
forefront of the diagnosis and management of dyslipidemia.
Featuring evidence-based, concise yet comprehensive discussion of
key clinical concepts in addition to numerous figures, tables and
illustrations, this pocket-sized handbook will serve as an
invaluable guide to healthcare professionals. Features: * Authored
by a renowned international group of experts on dyslipidemia. *
Chapters include vignettes to enhance clinical relevance.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.